How are CYP1A2 and gut health related?

The relationship between CYP1A2 and gut health is not well established in the scientific literature. CYP1A2 is a cytochrome P450 enzyme primarily expressed in the liver and also in the gut. It metabolizes caffeine, certain drugs, and activates dietary procarcinogens such as heterocyclic amines from grilled meat. Some research suggests that gut microbiota can modulate CYP1A2 activity – for example, via induction by plant compounds like indole-3-carbinol from cruciferous vegetables. Conversely, CYP1A2-mediated metabolism of xenobiotics might influence microbial composition. However, the evidence is mostly mechanistic, coming from animal or in vitro studies. Human intervention trials with clear gut health endpoints (e.g., inflammation markers, permeability) are lacking. Genetic variants like rs762551 („fast“ vs. „slow“ caffeine metabolizers) have small effect sizes and are not sufficient for personalized dietary advice. For improving gut health, focus on established factors: fiber, dietary diversity, and fermented foods – not single gene variants.